Literature DB >> 27122929

The Relation between the Timing of Percutaneous Coronary Intervention and Outcomes in Patients with Acute Coronary Syndrome with Routine Invasive Strategy - Data from Taiwan Acute Coronary Syndrome Full Spectrum Data Registry.

Cheng-Chun Wei1, Kou-Gi Shyu2, Jun-Jack Cheng3, Hei-Ming Lo4, Chiung-Zuan Chiu4.   

Abstract

BACKGROUND: Several large trials have indicated that a routine invasive strategy was favored for high-risk patients with non-ST-elevation acute coronary syndromes. However, the optimal timing for this intervention is unclear.
METHODS: We included patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI) from the Taiwan acute coronary syndrome registry. Thrombolysis in Myocardial Infarction (TIMI) score was used to stratify our patients into three groups: low (TIMI 0-2), intermediate (TIMI 3-4) and high risk (TIMI 5-7).We analyzed outcomes according to the timing of PCI.
RESULTS: Overall, 984 patients were included in this study. For primary outcomes including cardiac death and recurrent myocardial infarction, early PCI within 24 hours did not show benefits over late PCI (24-72 or > 72 hours) (p > 0.05) in the low and intermediate risk groups. However, in the high risk group, patients who underwent PCI after 72 hours had significantly worse primary outcomes than those who underwent PCI within 24-72 hours. For secondary outcomes including non-cardiac death, unplanned revascularization, and major bleeding, the events rate was significantly higher for early or delayed PCI in low-risk patients when compared with patients who underwent PCI within 24-72 hours.
CONCLUSIONS: In our study, for high-risk NSTE-ACS patients, PCI within 24-72 hours from symptom onset is demonstrably the optimum time for PCI. Delayed PCI over 72 hours is associated with the worst outcomes and should be avoided. For patients with low risks, routine early PCI < 24 hours after PCI is not beneficial. KEY WORDS: Acute coronary syndrome; Early invasive strategy.

Entities:  

Year:  2016        PMID: 27122929      PMCID: PMC4804939          DOI: 10.6515/acs20150722a

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  18 in total

1.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

2.  5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.

Authors:  K A A Fox; P Poole-Wilson; T C Clayton; R A Henderson; T R D Shaw; D J Wheatley; R Knight; S J Pocock
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

3.  The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Alice K Jacobs; Jeffrey L Anderson; Jonathan L Halperin
Journal:  J Am Coll Cardiol       Date:  2014-08-04       Impact factor: 24.094

4.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

5.  Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.

Authors:  R Spacek; P Widimský; Z Straka; E Jiresová; J Dvorák; R Polásek; I Karel; R Jirmár; L Lisa; T Budesínský; F Málek; P Stanka
Journal:  Eur Heart J       Date:  2002-02       Impact factor: 29.983

6.  Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry.

Authors:  Fu-Tien Chiang; Kou-Gi Shyu; Chiung-Jen Wu; Guang-Yuan Mar; Charles Jia-Yin Hou; Ai-Hsien Li; Ming-Shien Wen; Wen-Ter Lai; Shing-Jong Lin; Chi-Tai Kuo; Chieh Kuo; Yi-Heng Li; Juey-Jen Hwang
Journal:  J Formos Med Assoc       Date:  2013-09-26       Impact factor: 3.282

7.  AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services.

Authors:  Donna K Arnett; Richard A Goodman; Jonathan L Halperin; Jeffrey L Anderson; Anand K Parekh; William A Zoghbi
Journal:  J Am Coll Cardiol       Date:  2014-09-11       Impact factor: 24.094

8.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

Authors: 
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

9.  Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.

Authors:  W E Boden; R A O'Rourke; M H Crawford; A S Blaustein; P C Deedwania; R G Zoble; L F Wexler; R E Kleiger; C J Pepine; D R Ferry; B K Chow; P W Lavori
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

10.  Prognostic significance of new onset atrial fibrillation in acute coronary syndrome patients treated conservatively.

Authors:  Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Jacek Jakała; Jacek S Dubiel; Dariusz Dudek
Journal:  Cardiol J       Date:  2010       Impact factor: 2.737

View more
  4 in total

Review 1.  The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry.

Authors:  Chun-Yuan Chu; Tsung-Hsien Lin; Wen-Ter Lai
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

2.  Changing Practice Pattern of Acute Coronary Syndromes in Taiwan from 2008 to 2015.

Authors:  Yi-Heng Li; Yu-Wei Chiu; Jun-Jack Cheng; I-Chang Hsieh; Ping-Han Lo; Meng-Huan Lei; Kwo-Chang Ueng; Fu-Tien Chiang; Shih-Hsien Sung; Jen-Yuan Kuo; Ching-Pei Chen; Wen-Ter Lai; Wen-Lieng Lee; Jyh-Hong Chen
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

3.  Clinical Outcomes of Polytetrafluoroethylene-Covered Stents for Coronary Artery Perforation in Elderly Patients Undergoing Percutaneous Coronary Interventions.

Authors:  Huang-Joe Wang; Jen-Jyh Lin; Wan-Yu Lo; Chih-Ping Chang; Chung-Ho Hsu; Li-Chuan Hsieh; Yeh-Peng Chen; Yen-Nien Lin; Kuan-Cheng Chang; Ping-Han Lo
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

4.  Effect of different revascularization times on intermediate-risk non-ST-elevation acute coronary syndrome.

Authors:  Xiangyong Kong; Jun Yin; Ningtian Zhou; Likun Ma; Hongwu Chen; Jiawei Wu; Xiaofan Yu
Journal:  Sci Rep       Date:  2022-09-20       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.